Informatie:
Fout:
ID
34410
Beschrijving
Dalfampridine for Imbalance in Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT01444300
Link
https://clinicaltrials.gov/show/NCT01444300
Trefwoorden
Versies (1)
- 17-01-19 17-01-19 -
Houder van rechten
see on clinicaltrials.gov
Geüploaded op
17 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Multiple Sclerosis NCT01444300
Eligibility Multiple Sclerosis NCT01444300
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Sclerosis NCT01444300
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
age 20- 59 years,
boolean
ID.2
Item
able to walk at least 100m without an aide or with unilateral assistance
boolean
ID.3
Item
prolonged apr latencies (≥ 1sd > mean for healthy people in this age range) or,
boolean
ID.4
Item
reduced balance-related activity (abc scores ≤ 85%),
boolean
ID.5
Item
abnormal trunk range of motion (horizontal), trunk range of motion (frontal), turning duration, cadence, double support time, stride length or gait cycle time (outside 1sd of the average for healthy people in this age range)
boolean
ID.6
Item
currently taking dalfampridine (any within the last 2 weeks),
boolean
ID.7
Item
cause(s) of imbalance other than ms,
boolean
ID.8
Item
impaired renal function (creatinine clearance ≤50ml/min),
boolean
ID.9
Item
seizure disorder
boolean
ID.10
Item
pregnancy or breast feeding
boolean